n/a
Article Publish Status: FREE
Abstract Title:

Potential of the ellagic acid-derived gut microbiota metabolite - Urolithin A in gastrointestinal protection.

Abstract Source:

World J Gastroenterol. 2020 Jun 21 ;26(23):3170-3181. PMID: 32684733

Abstract Author(s):

Małgorzata Kujawska, Jadwiga Jodynis-Liebert

Article Affiliation:

Małgorzata Kujawska

Abstract:

Urolithin A (UA) is a metabolic compound generated during the biotransformation of ellagitannins by the intestinal bacteria. The physiologically relevant micromolar concentrations of UA, achieved in the plasma and gastrointestinal tract (GI) after consumption of its dietary precursors, have been revealed to offer GI protection. The health benefit has been demonstrated to be principally related to anticancer and anti-inflammatory effects. UA has been shown to possess the capability to regulate multiple tumor and inflammatory signaling pathways and to modulate enzyme activity, including those involved in carcinogen biotransformation and antioxidant defense. The purpose of this review is to gather evidence from bothandstudies showing the potential of UA in GI protection alongside suggested mechanisms by which UA can protect against cancer and inflammatory diseases of the digestive tract. The data presented herein, covering both studies on the pure compound andgenerated UA form its natural precursor, support the potential of this metabolite in treatment interventions against GI ailments.

Print Options


This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.